Research Articles | Page 27 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Ravulizumab: a novel C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria Sep 2019 Therapeutic Advances in Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis Jun 2019 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Real-world Effectiveness of Azacitidine in Treatment-Naive Patients With Higher-risk Myelodysplastic Syndromes Apr 2024 Clinical Lymphoma, Myeloma & Leukemia Myelodysplastic Syndromes (MDS)
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes May 2023 Journal of Clinical Oncology Myelodysplastic Syndromes (MDS)
Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia Mar 2023 International Journal of Hematology Aplastic Anemia
Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes Apr 2019 Blood Myelodysplastic Syndromes (MDS)
Rethinking clinical trial endpoints in myelodysplastic syndromes. Jan 2019 Leukemia Myelodysplastic Syndromes (MDS)
Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant. Jan 2019 Crit Rev Oncol Hematol Myelodysplastic Syndromes (MDS)
Rewriting the rules for care of MDS and AML patients in the time of COVID-19 Apr 2020 Leukemia Research Reports Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Rigosertib in Combination With Azacitidine in Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia: Results of a Phase 1 Study Jul 2020 Leukemia Research Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)